EXIT071
PrivateLast Round
Seed
Mar 24, 2025
Total Funding Raised
$2.56M
Company Overview
EXIT071 B.V. is a biotechnology company that develops an integrated and automated platform for exosome isolation and molecular analysis for biomarker discovery, diagnostics, and therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EXIT071 Comparables
Compare EXIT071 with similar companies based on industry and business-model similarity.
EXIT071 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 24, 2025 | ||||
| Grant | Mar 28, 2022 | ||||
| Seed | Feb 15, 2022 |
Key People
Founding team and executive leadership
EXIT071 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| Libertatis Ergo Holding | Seed |
EXIT071 Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EXIT071's valuation, stock price, and market status.